Schedule 13G ownership disclosure
Janux Therapeutics Inc
Common Stock · CUSIP: 47103J105
Event date: 2025-10-31
- Filing-level shares
- 6,033,949
- Percent of class
- 10.0%
- JANUS HENDERSON GROUP PLC
Shares: 6,033,949 · Class: 10.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000262
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Nov 07, 2025
- Reporting period
- Oct 31, 2025
- Description
- Schedule 13G beneficial ownership